What to expect from European Affairs at EHA2024

2940 20230609

European Affairs gives a voice to hematology professionals in Europe.

Read more

Streamlining SoHO Management in EU Hospitals

The European Commission's Directorate-General for Health and Food Safety (DG SANTE) is committed to improving the management of Substances of Human Origin (SoHO) in EU hospitals.

Read more

The European Parliament adopts the Regulation on Substances of Human Origins (So…

AdobeStock 75539245

On April 24, the European Parliament gave its final endorsement to the regulation on Substances of Human Origin (SoHO).

Read more

Parliament puts final stamp on the European Health data Space

Untitled design

On April 24, the European Parliament gave its final endorsement to the regulation on the European Health Data Space (EHDS).

Read more

EHA attends the EuNet-INNOCHRON Final Conference

Innochron

The EuNet-INNOCHRON Final Conference, a significant event in the field of hematology, took place in Chania, Crete, Greece from April 4-6, 2024.

Read more

EU Parliament agrees on pharmaceutical legislation stance

Website EUR Affairs Pharmaceutical Legislation

On April 10, the European Parliament adopted its position on the revision of the EU pharmaceutical legislation.

Read more

EHA ‘Excellence in Hematology’ Survey now online

AdobeStock 192335240

Excellence in Hematology is created together. Would you help us out? This week, we’re starting an important research endeavor – our ‘Excellence in hematology’ survey.

Read more

EHA mapping of adolescent and young adult (AYA) hematology patient care

AdobeStock 476750341 AYA Survey

EHA has launched a major consultation to understand patient care for Adolescents and Young Adults (AYA) with hematological diagnoses across Europe.

Read more

Cancer Medicines Forum workshop April 5: a way forward for treatment optimizatio…

martin kaiser headshot

The Cancer Medicines Forum (CMF) is hosted by the European Medicines Agency (EMA) in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC).

Read more

The 'i4MDS' consortium looks to the future at its second general meeting

i4MDS 1
Feb 29 2024 Posted in Meeting reports Tagged i4MDS

The International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—also known as ' i4MDS'—held its second general meeting in The Hague from February 9–10, 2024.

Read more

EHA-ECL led statement calls for protection of the Hospital Exemption

EUR Affairs Hospital Exemption 1920 x 1080 px 1

The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.

Read more

Urgent action needed to avoid widespread shortage of in-vitro diagnostic tests

AdobeStock 135134857

In a new statement, BioMed Alliance highlights its increasing concern about the availability of In Vitro Diagnostic (IVD) testing devices in Europe.

Read more

Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU adv…

EHA joins ACT EU advisory board image

Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.

Read more

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) …

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy…

Read more

Belgium shares EU health priorities for Council Presidency

EHA Newsblog Belgium EU Council Presidency

On December 8, Belgium held a conference to unveil its program for the upcoming Council of the EU Presidency (website), to start on January 1, 2024.

Read more